Standout Papers

Adult eczema prevalence and associations with asthma and other health and demographic factors: A U... 2013 2026 2017 2021 462
  1. Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population–based study (2013)
    Jonathan I. Silverberg, Jon M. Hanifin Journal of Allergy and Clinical Immunology
  2. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis (2018)
    Emma Guttman‐Yassky, Robert Bissonnette et al. Journal of Allergy and Clinical Immunology
  3. Global Skin Disease Morbidity and Mortality (2017)
    Chanté Karimkhani, Robert P. Dellavalle et al. JAMA Dermatology
  4. Patient burden and quality of life in atopic dermatitis in US adults (2018)
    Jonathan I. Silverberg, Joel M. Gelfand et al. Annals of Allergy Asthma & Immunology
  5. Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb (2018)
    Andreas Wollenberg, Michael Howell et al. Journal of Allergy and Clinical Immunology
  6. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis (2021)
    Thomas Bieber, Eric L. Simpson et al. New England Journal of Medicine
  7. Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis (2020)
    Jonathan I. Silverberg, Eric L. Simpson et al. JAMA Dermatology
  8. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population (2018)
    Zelma C. Chiesa Fuxench, Julie Block et al. Journal of Investigative Dermatology
  9. Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder (2016)
    Patrick M. Brunner, Jonathan I. Silverberg et al. Journal of Investigative Dermatology
  10. Public Health Burden and Epidemiology of Atopic Dermatitis (2017)
    Jonathan I. Silverberg Dermatologic Clinics
  11. Comorbidities and the impact of atopic dermatitis (2019)
    Jonathan I. Silverberg Annals of Allergy Asthma & Immunology
  12. Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial (2019)
    Emma Guttman‐Yassky, Diamant Thaçi et al. Journal of Allergy and Clinical Immunology
  13. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021)
    Kristian Reich, Henrique D. Teixeira et al. The Lancet
  14. Atopic dermatitis in the pediatric population (2021)
    Jonathan I. Silverberg, S. Barbarot et al. Annals of Allergy Asthma & Immunology
  15. Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial* (2020)
    Jonathan I. Silverberg, D. Toth et al. British Journal of Dermatology
  16. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis (2023)
    Jonathan I. Silverberg, Emma Guttman‐Yassky et al. New England Journal of Medicine
  17. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies (2023)
    Dawn Marie R. Davis, Aaron M. Drucker et al. Journal of the American Academy of Dermatology
  18. Guidelines of care for the management of atopic dermatitis in adults with topical therapies (2023)
    Robert Sidbury, Ali Alikhan et al. Journal of the American Academy of Dermatology

Immediate Impact

7 from Science/Nature 112 standout
Sub-graph 1 of 18

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Atopic dermatitis
2025 Standout
132 intermediate papers

Works of Jonathan I. Silverberg being referenced

Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials
2024
Comorbidities of atopic dermatitis—what does the evidence say?
2023
and 141 more

Author Peers

Author Last Decade Papers Cites
Jonathan I. Silverberg 18207 13330 6679 753 22.4k
Johannes Ring 14552 16613 7824 707 30.3k
Jon M. Hanifin 13754 10762 5266 245 18.7k
Jacob P. Thyssen 13820 7269 2591 634 18.1k
Gil Yosipovitch 10003 4215 2889 457 13.3k
Alan D. Irvine 11158 8114 3699 292 16.6k
Sonja Ständer 9756 4005 2788 427 13.3k
Masutaka Furue 7738 3666 2683 722 16.7k
A.Y. Finlay 14495 4423 2570 269 21.5k
Giampiero Girolomoni 9588 3720 3102 539 23.0k
Lawrence F. Eichenfield 8376 5100 2007 432 11.5k

All Works

Loading papers...

Rankless by CCL
2026